FDG PET/CT demonstration of pancreatic metastasis from prostate cancer.
FDG PET/CT demonstration of pancreatic metastasis from prostate cancer.
复制标题
DOI：
10.1097/rlu.0b013e3182291d1a
复制
发表时间：
2011-10
影响因子：
10.6
通讯作者：
Jadvar H
中科院分区：
文献类型：
--
作者：
Desai B;Elatre W;Quinn DI;Jadvar H
我们报告了一例去势抵抗性转移性疾病男性患者经活检证实的前列腺癌胰腺转移的混合FDG PET/CT表现。前列腺癌转移的常见部位是骨和局部淋巴结。胰腺是前列腺癌转移的非典型部位。在这种情况下，PET/CT有助于有针对性的病理确认，以区分原发性胰腺肿瘤与前列腺癌的不寻常转移，这反过来又影响了临床管理。
We report the hybrid FDG PET/CT appearance of a biopsy-proven pancreatic metastasis from prostate cancer in a man with castrate-resistant metastatic disease. The common sites of metastases from prostate cancer are bone and locoregional lymph nodes. Pancreas is an atypical location of metastasis from prostate cancer. PET/CT in this case helped with the targeted pathologic confirmation to differentiate primary pancreatic tumor from an unusual metastasis from prostate cancer which in turn impacted the clinical management.